Related Experiment Video
Updated: Mar 9, 2026
09:16
A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration
Published on: January 22, 2016
15.9K
Parthenolide inhibits methamphetamine-induced depressive-like behavior by targeting ADORA2A
Rongji Hui1, Tao Feng2, Congcong Hou3
1College of Forensic Medicine, Hebei Medical University, Hebei Key Laboratory of Forensic Medicine, Collaborative Innovation Center of Forensic Medical Molecular Identification, Hebei Province, Shijiazhuang 050017, China; Hebei Medical University Basic Medicine Postdoctoral Research Station, Hebei Province, Shijiazhuang 050017, China.
Summary
Parthenolide effectively treats methamphetamine-induced depression-like behaviors by targeting ADORA2A signaling in the medial prefrontal cortex (mPFC). This natural compound shows promise for substance-induced mood disorders.
Area of Science:
- Neuroscience
- Pharmacology
- Molecular Biology
Background:
- Methamphetamine (METH) abuse causes persistent depressive behaviors with limited treatment options.
- Parthenolide, a natural compound, has neuroprotective and anti-inflammatory effects but its role in METH-induced depression is unstudied.
Purpose of the Study:
- To investigate parthenolide's efficacy in alleviating METH-induced depressive behaviors.
- To identify key brain regions and molecular targets involved in parthenolide's therapeutic effects.
Main Methods:
- Mice received METH and parthenolide treatment, followed by behavioral, histological, and neural activity assessments.
- Metabolomics and network pharmacology predicted targets, validated through molecular docking, simulations, and assays.
- Pharmacological modulation confirmed the role of identified targets.
Main Results:
- Parthenolide significantly ameliorated METH-induced depressive-like behaviors in mice.
- The medial prefrontal cortex (mPFC) was identified as a key region affected by METH, with parthenolide reducing neuronal damage.
- ADORA2A was identified as a crucial molecular target, validated by pharmacological experiments.
Conclusions:
- Parthenolide alleviates METH-induced depression by modulating ADORA2A signaling within the mPFC.
- This study provides mechanistic insights into parthenolide's antidepressant-like effects.
- Parthenolide is a potential therapeutic candidate for substance-induced mood disorders.
Related Concept Videos
01:25Adrenergic Agonists: Indirect-Acting Agents
2.9K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
2.9K
01:21Drugs Affecting Neurotransmitter Release or Uptake
1.7K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.7K
01:29Drugs Affecting Neurotransmitter Synthesis
2.4K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
2.4K
01:23Antidepressant Drugs: MAOIs and Other Agents
1.1K
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
1.1K
01:20Desensitization and Tachyphylaxis
3.3K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
3.3K
01:16Adrenergic Agonists: Chemistry and Structure-Activity Relationship
4.0K
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
4.0K